West Pharmaceutical Services recently introduced its latest Daikyo Crystal Zenith 2.25 ml insert needle syringe system. The global pharmaceutical company announced the news at the BIO International Convention in San Diego, California.
West Pharma, a well-renowned company in innovative solutions for injectable drugs, introduced the new Daikyo Crystal Zenith 2.25 ml insert needle syringe system.
The global company announced at the BIO International Convention that took place from 13-16 June 2022. The new syringe system is an expansion of the company’s Daikyo Crystal Zenith that offers an innovative alternative to age-old syringes.
All-new insert syringe systems from West Pharma
West Pharma’s latest innovation is an up-gradation of its Daikyo Crystal Zenith 1ml syringe system that uses a cyclic olefin polymer containment and delivery system. It is an alternative solution to glass and prevents the risk of mishandling and breakage. Also, it alleviates the risk of particulates, extractable, and contamination.
Since there is a requirement for high doses of injections, the need for a larger syringe size system also grows. With the new size of 2.25 ml, a larger volume of injections is now possible. The new size will help pharmaceutical companies safely make their products available to patients in a more user-centric model.
Li Chen, vice-president and general manager of Biologics at West Pharma, said in a statement that they can now bring solutions to the needs of more patients with their new larger fill volume in the CZ insert needle syringe system. Their high-quality CZ insert needle syringe system is a safe and reliable containment solution.
Li Chen further states that with their 2.25 ml insert needle syringe system, patients won’t have to take multiple injections to fulfil their dose. The new syringe system will allow fewer or less frequent injections, which will enable an easier patient experience.
West Pharma’s partnership with Daikyo
Daikyo Seiko has the license for Crystal Zenith technology. The company manufactures Crystal Zenith, a registered trademark of Daikyo Seiko, and West Pharma, a leading manufacturer of innovative and high-quality syringe systems and solutions.
In an exclusive distributor arrangement, West Pharma has collaborated with Daikyo. This partnership intends to bring their innovative new Insert Syringe System with high dose capacity to a global market.
Patients and pharmaceutical companies will benefit from the new syringe size to administer medicines effectively because there is a progressive need for high doses. Earlier, patients had to take multiple injections to complete their dose, and the whole experience was strenuous. With high dose capacity, the new syringes can administer the same dose in just one injection.
With its highly effective and efficient solutions, West provides safe containment and delivery of life-saving drugs to patients. The introduction of the high-volume insert syringe system paves the way to making the whole experience of the journey towards health much easier for patients.
